Orgenesis (FRA:45O) Beginning Cash Position : €0.53 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Beginning Cash Position?

Orgenesis's Beginning Cash Position for the quarter that ended in Jun. 2024 was €0.53 Mil.

Orgenesis's quarterly Beginning Cash Position increased from Dec. 2023 (€0.72 Mil) to Mar. 2024 (€1.36 Mil) but then declined from Mar. 2024 (€1.36 Mil) to Jun. 2024 (€0.53 Mil).

Orgenesis's annual Beginning Cash Position declined from Dec. 2021 (€40.33 Mil) to Dec. 2022 (€5.64 Mil) but then increased from Dec. 2022 (€5.64 Mil) to Dec. 2023 (€5.84 Mil).

Orgenesis Beginning Cash Position Historical Data

The historical data trend for Orgenesis's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Beginning Cash Position Chart

Orgenesis Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

13.50

9.90

40.33

5.64

5.84

Orgenesis Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Beginning Cash Position	Get a 7-Day Free Trial															3.44	1.15	0.72	1.36	0.53

Orgenesis Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Orgenesis Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Orgenesis's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Orgenesis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ORGS:USA

Address

20271 Goldenrod Lane, Germantown, MD, USA, 20876

Website

https://www.orgenesis.com

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis Headlines

No Headlines